- Patients with a diagnosis of a solid malignancy that is refractory to standard
therapy or for which no standard therapy exists.
- Patients has a good performance status (ECOG 0 or 1)
- Prior treatment with either pemetrexed or SU011248.
- Coughing up blood within 4 weeks before starting study treatment (small amounts
- Hypertension that cannot be controlled by medications.